Moderna, Inc. MRNA revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Moderna, Inc. reported revenue across 8 products and services; the largest, Product Sales, was $1.82B (-41.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product Sales$1.82Bshare n/a-41.5% yoy
- COVID19$1.81Bshare n/a-41.3% yoy
- Product And Service Other$126Mshare n/a-0.8% yoy
- Stand Ready Manufacturing Revenue$80Mshare n/ano prior
- Grant$22Mshare n/a-40.5% yoy
- Collaboration Arrangement Including Arrangements With Affiliate$13Mshare n/a-72.9% yoy
- License And Royalty$11Mshare n/a-73.8% yoy
- RSV$8Mshare n/a-68.0% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$1.2B61.7%-32.8% yoy
- Rest of world$692M35.6%-18.9% yoy
- Europe$53M2.7%-91.1% yoy
Members sum to the consolidated $1.94B for this period.
- Product Sales$94Mshare n/a-17.5% yoy
- COVID19$91Mshare n/a-20.2% yoy
- Product And Service Other$51Mshare n/a+82.1% yoy
- Stand Ready Manufacturing$31Mshare n/a+82.4% yoy
- Collaboration Arrangement Including Arrangements With Affiliate$15Mshare n/a+275.0% yoy
- RSV$3Mshare n/ano prior
- +2 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.